Literature DB >> 9272363

Bordetella pertussis-specific Th1/Th2 cells generated following respiratory infection or immunization with an acellular vaccine: comparison of the T cell cytokine profiles in infants and mice.

M Ryan1, L Gothefors, J Storsaeter, K H Mills.   

Abstract

In an investigation of cell-mediated immunity against Bordetella pertussis, we found that B. pertussis infection in infants and in mice was associated with the induction of antigen-specific T cells that secrete IFN-g and IL-2, but not IL-4 or IL-5. This cytokine profile is characteristic of Th1 cells that mediate cellular immune responses against a range of intracellular pathogens. An examination of cytokine production following immunization with a three-component acellular vaccine, comprising inactive PT, FHA and pertactin adsorbed to alum, demonstrated that spleen cells from vaccinated mice produced high levels of IL-5, but no detectable IFN-g and low levels of IL-2. In contrast, peripheral blood mononuclear cells from vaccinated infants produced IL-2, IL-5 and IFN-g. These findings highlight significant differences in the immune responses generated by vaccination and natural infection with B. pertussis and demonstrate that the T-cell response induced with an acellular vaccine, although dominated by type 2 cytokines in mice, is more heterogeneous in infants with a Th0 or mixed Th1/Th2 cytokine profile.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9272363

Source DB:  PubMed          Journal:  Dev Biol Stand        ISSN: 0301-5149


  18 in total

1.  Immune responses to pertussis antigens in infants and toddlers after immunization with multicomponent acellular pertussis vaccine.

Authors:  Olajumoke O Fadugba; Li Wang; Qingxia Chen; Natasha B Halasa
Journal:  Clin Vaccine Immunol       Date:  2014-09-24

2.  Protective effects of pertussis immunoglobulin (P-IGIV) in the aerosol challenge model.

Authors:  J B Bruss; G R Siber
Journal:  Clin Diagn Lab Immunol       Date:  1999-07

Review 3.  Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.

Authors:  Seema Mattoo; James D Cherry
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

4.  Acellular Bordetella pertussis vaccine enhances mucosal interleukin-10 production, induces apoptosis of activated Th1 cells and attenuates colitis in Galphai2-deficient mice.

Authors:  L Ohman; R Willén; O H Hultgren; E Hultgren Hörnquist
Journal:  Clin Exp Immunol       Date:  2005-07       Impact factor: 4.330

5.  Humoral and cellular immune responses in mice immunized with recombinant Mycobacterium bovis Bacillus Calmette-Guérin producing a pertussis toxin-tetanus toxin hybrid protein.

Authors:  B Abomoelak; K Huygen; L Kremer; M Turneer; C Locht
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

6.  Immunological development of preterm infants in early infancy.

Authors:  B Zhang; Y Ohtsuka; T Fujii; H Baba; K Okada; H Shoji; S Nagata; T Shimizu; Y Yamashiro
Journal:  Clin Exp Immunol       Date:  2005-04       Impact factor: 4.330

7.  Acellular pertussis vaccination facilitates Bordetella parapertussis infection in a rodent model of bordetellosis.

Authors:  Gráinne H Long; Alexia T Karanikas; Eric T Harvill; Andrew F Read; Peter J Hudson
Journal:  Proc Biol Sci       Date:  2010-03-03       Impact factor: 5.349

8.  Effect of different forms of adenylate cyclase toxin of Bordetella pertussis on protection afforded by an acellular pertussis vaccine in a murine model.

Authors:  Gordon Y C Cheung; Dorothy Xing; Sandra Prior; Michael J Corbel; Roger Parton; John G Coote
Journal:  Infect Immun       Date:  2006-09-18       Impact factor: 3.441

9.  Expression of the lipopolysaccharide-modifying enzymes PagP and PagL modulates the endotoxic activity of Bordetella pertussis.

Authors:  Jeroen Geurtsen; Liana Steeghs; Hendrik-Jan Hamstra; Jan Ten Hove; Alex de Haan; Betsy Kuipers; Jan Tommassen; Peter van der Ley
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

10.  Pertussis toxin utilizes proximal components of the T-cell receptor complex to initiate signal transduction events in T cells.

Authors:  Olivia D Schneider; Alison A Weiss; William E Miller
Journal:  Infect Immun       Date:  2007-06-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.